Synvina plans to extend FDCA pilot phase to optimize future commercial-scale production
Type of post: NEWS IN BRIEF.
The Blog is following with interest the
advancements in the commercialization of the 2,5-furandicarboxylic acid (FDCA),
one of the most promising platform molecules in the biorefining landscape and key
building block for the biopolymer PEF. Synvina
lead the group. It is a joint venture of Avantium
and BASF established in in October 2016
with the intent to build and operate a reference plant for FDCA production.
But, the path forward is not smooth.
Synvina has now completed a broad feasibility
assessment for commercial-scale production in the reference plant which will be
located in Antwerp. The assessment looked at product performance, market appetite
and technical process. It confirmed that product performance and customer
demand are strong. In the technical process evaluation, Synvina identified some
steps that require improvement. It recommends undertaking additional
development work on these steps, to ensure the most efficient process and best
product for current and future customers. As a result, Synvina intends to
extend the pilot phase, which will in turn extend the timeline to start up the reference
plant by 24 to 36 months. It could be operational in the 2023-2024 timeframe.
More information about this news: Avantium press
release, 12/01/2018.
More information about the FDCA: FDCA biorefineries.
Other news about the FDCA: FDCA
label.